JNJ

JOHNSON & JOHNSON

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

JOHNSON & JOHNSON (JNJ) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$2.57B; the largest are Jeremy Grantham, Ken Griffin, Ray Dalio. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 5 trimmed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Cooling

Common-stock holders74 also report options

Congress trades20

Price$271.95vs quarter-end+7.08%

Sectors1

This quarter's moves

New0

Added1

Trimmed / sold5

Top holderJeremy Grantham

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Dodge & CoxHold

Value $5.32M0.0% of portfolio20,9472026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Dodge & Cox	2026 Q2	$5.32M	20,947	0.0%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $933.01M— of portfolio3,673,7002026 Q2

Ken GriffinPUT—

Value $816.26M— of portfolio3,214,0002026 Q2

Steven CohenPUT—

Value $483.84M— of portfolio1,905,1002026 Q2

Izzy EnglanderPUT—

Value $287.19M— of portfolio1,130,8002026 Q2

Izzy EnglanderCALL—

Value $111.57M— of portfolio439,3002026 Q2

Steven CohenCALL—

Value $65.09M— of portfolio256,3002026 Q2

Paul Tudor JonesCALL—

Value $34.39M— of portfolio135,4002026 Q2

Paul Tudor JonesPUT—

Value $13.49M— of portfolio53,1002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$933.01M	3,673,700	—	—
Ken GriffinPUT	2026 Q2	$816.26M	3,214,000	—	—
Steven CohenPUT	2026 Q2	$483.84M	1,905,100	—	—
Izzy EnglanderPUT	2026 Q2	$287.19M	1,130,800	—	—
Izzy EnglanderCALL	2026 Q2	$111.57M	439,300	—	—
Steven CohenCALL	2026 Q2	$65.09M	256,300	—	—
Paul Tudor JonesCALL	2026 Q2	$34.39M	135,400	—	—
Paul Tudor JonesPUT	2026 Q2	$13.49M	53,100	—	—

Insider Trading

Officers · directors · Form 4

Open-market purchases and sales (P/S)11

Timothy Schmid
EVP, WW Chair, MedTech
Sell$3.04M
11,070 @ $274.74Traded 2026-09-02Filed 2026-09-04
Timothy Schmid
EVP, WW Chair, MedTech
Sell$6.19M
22,527 @ $274.74Traded 2026-09-02Filed 2026-09-04
Jennifer L Taubert
EVP, WWC. Innovative Medicine
Sell$3.95M
15,000 @ $263.36Traded 2026-08-17Filed 2026-08-18
Joaquin Duato
CEO and Chairman of the Board
Sell$26.70M
102,315 @ $261.00Traded 2026-08-13Filed 2026-08-14
Joaquin Duato
CEO and Chairman of the Board
Sell$5.50M
20,976 @ $262.00Traded 2026-08-13Filed 2026-08-14
Elizabeth Forminard
EVP, Chief Legal Officer
Sell$2.41M
9,344 @ $257.75Traded 2026-08-06Filed 2026-08-07
Elizabeth Forminard
EVP, Chief Legal Officer
Sell$1.68M
6,574 @ $255.93Traded 2026-08-06Filed 2026-08-07
Joaquin Duato
CEO and Chairman of the Board
Sell$10.83M
41,957 @ $258.06Traded 2026-08-05Filed 2026-08-07
Joaquin Duato
CEO and Chairman of the Board
Sell$1.69M
6,523 @ $258.74Traded 2026-08-05Filed 2026-08-07
Vanessa Broadhurst
EVP, Global Corp Affairs
Sell$5.79M
23,054 @ $251.27Traded 2026-07-20Filed 2026-07-21
Kathryn E Wengel
EVP, Chief TO and Risk Officer
Sell$2.41M
10,000 @ $241.15Traded 2026-06-11Filed 2026-06-12

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.